An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection

Clinical trial NCT03692897 · TERMINATED

Trial details

NCT number: NCT03692897
Sponsor: Target PharmaSolutions, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Hepatitis B Hepatitis Liver Diseases

Start date: 2018-10-11
Primary completion: 2025-09-10
Enrollment: 1708

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.